Skip to main content
News Icon

Honors & Funding

Preliminary Results DFG Review Board

The preliminary results of the election for the DFG Review Board are online.

Three members of the Cluster of Excellence ImmunoSensation2 were voted into the DFG Review Board.

Here are the members of the DFG Review Board 2019 from ImmunoSensation2:

Achim Hörauf (FK204-06 Parasitologie & Biologie der Erreger tropischer Infektionskrankheiten)

Irmgard Förster (FK 204-05 Immunologie)

Waldemar Kolanus (FK 201-03 Zellbiologie)

Related news

Prof. Dr. Kaan Boztug

Honors & Funding

Kaan Boztug awarded Novartis Prize

—Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry
Niklas Klümper

Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

—PD Dr. Niklas Klümper was honored with the prestigious Johann-Georg-Zimmermann Research Prize. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions.
View entry
Speakers of ImmunoSensation

Honors & Funding

ImmunoSensation goes into the next round

—The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry

Back to the news overview